Carlsmed, Inc. (CARL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet
Carlsmed, Inc. (CARL) Q1 2026 Earnings Call Transcript
Carlsmed, Inc. (CARL) Reports Q1 Loss, Tops Revenue Estimates
Carlsmed® Reports First Quarter 2026 Financial Results
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
Carlsmed Showcases Personalized Spine Fusion Gains, Cervical Expansion and Medicare Tailwinds at Needham Conf
Carlsmed Inc. to Report First Quarter 2026 Financial Results on May 5, 2026
Comparing MiniMed Group (NASDAQ:MMED) and Carlsmed (NASDAQ:CARL)
Carlsmed, Inc. To Participate in the 25th Annual Needham Virtual Conference
Financial Contrast: Carlsmed (NASDAQ:CARL) & Predictive Oncology (NASDAQ:AGPU)
Contrasting Carlsmed (NASDAQ:CARL) and Medline (NASDAQ:MDLN)
Head-To-Head Analysis: Carlsmed (NASDAQ:CARL) versus Predictive Oncology (NASDAQ:AGPU)
Carlsmed Unveils Personalized Spine Platform, Targets $70M-$75.5M 2025 Revenue at Conference
Critical Contrast: Carlsmed (NASDAQ:CARL) vs. Check-Cap (NASDAQ:MBAI)
Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference
Head to Head Survey: Carlsmed (NASDAQ:CARL) & Check-Cap (NASDAQ:MBAI)
Nanovibronix (NASDAQ:FEED) & Carlsmed (NASDAQ:CARL) Critical Review
Carlsmed Unveils Custom Cervical Plating Tech
Carlsmed Announces first corra™ personalized Cervical Plating Procedure
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure
Head-To-Head Review: Profusa (NASDAQ:PFSA) versus Carlsmed (NASDAQ:CARL)
Carlsmed (NASDAQ:CARL) & Profusa (NASDAQ:PFSA) Financial Survey
Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
Carlsmed, Inc.’s Lock-Up Period Set To End on January 19th (NASDAQ:CARL)
Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal
Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance
Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025
Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index
Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025
Carlsmed's aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures
These 4 Stocks Are Seeing Huge Insider Buying
Carlsmed's aprevo® Powers First Personalized Cervical Spine Surgery
Carlsmed: Spine Play Does Not Have My Backing Yet
Carlsmed Announces Pricing of Initial Public Offering
Carlsmed Announces Launch of Initial Public Offering
U.S. IPO Weekly Recap: Mining Companies Lead The Calendar As More Sizable IPOs Submit Initial Filings
Carlsmed Announces Launch of Initial Public Offering
Carlsmed Files For IPO On High Growth And High Operating Losses